Story perspectives

Novo Nordisk Mandates Office Return Amid Job Cuts

9/12/2025

Summary

Story summary

Novo Nordisk requires all staff to return to the office to improve decision-making and commercial execution under the new CEO.
The company plans to eliminate 9,000 jobs due to declining sales growth and a $450 billion drop in market cap.
Increased competition from Eli Lilly and similar drugs adds pressure on Novo.
Employees may negotiate flexible work arrangements with managers.
Other firms, like JPMorgan Chase and Amazon, have also ended remote work policies.

History

Historical Context

The global financial crisis of 2007-2008 resulted in the U.S. economy losing approximately 8.7 million jobs, prompting significant corporate restructuring, including layoffs at JPMorgan Chase. In 2023, Novo Nordisk announced plans to cut 9,000 jobs amid rising competition from Eli Lilly, reflecting ongoing shifts in corporate strategies and a potential return to traditional work environments, impacting employee flexibility and corporate culture.

1 of 2

Story summary

Novo Nordisk requires all staff to return to the office to improve decision-making and commercial execution under the new CEO.
The company plans to eliminate 9,000 jobs due to declining sales growth and a $450 billion drop in market cap.
Increased competition from Eli Lilly and similar drugs adds pressure on Novo.
Employees may negotiate flexible work arrangements with managers.
Other firms, like JPMorgan Chase and Amazon, have also ended remote work policies.

1 / 2